Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators

Journal of Cardiovascular Electrophysiology

Volumn 10, Issue 2, 1999, Pages 145-153

  Weber, Max ^a,b   Böcker, Dirk ^a   Bänsch, Dietmar ^a   Brunn, Jürgen ^a   Castrucci, Marco ^a   Gradaus, Rainer ^a   Breithardt, Günter ^a   Block, Michael ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Atrial fibrillation; Detection criteria; Implantable cardioverter defibrillator; Inappropriate therapies; Sinus tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS TACHYCARDIA;

EID: 0032968439     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1999.tb00655.x     Document Type: Article

References (27)

1. Block M, Breithardt G: Long-term follow-up and clinical results of implantable cardioverter-defibrillators. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders Company, Philadelphia, 1995, pp. 1412-1425.
2. Weber M, Block M, Brunn J, et al: Inappropriate ICD therapies: Incidence, causes, risk factors and prevention. Z Kardiol 1996;85:808-819.
3. Grimm W, Flores BF, Marchlinski FE: Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. PACE 1992;15:1667-1673.
4. Schmitt C, Montero M, Melichercik J: Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. PACE 1994;17:295-302.
5. Mattke S, Dorwarth U, Müller D, et al: Inadequate therapy delivery by implantable cardioverter-defibrillator: Reasons, therapy and prevention. Z Kardiol 1994;83:359-365.
6. Fromer M, Brachmann J, Block M, et al: Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Circulation 1992;86:363-374.
7. Maloney J, Masterson M, Khoury D, et al: Clinical performance of the implantable cardioverter defibrillator: Electrocardiographic documentation of 101 spontaneous discharges. PACE 1991;14:280-285.
8. Nunain SO, Roelke M, Trouton T, et al: Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 1995;91:2204-2213.
9. Cohen TJ, Chien WW, Lurie KG, et al: Implantable cardioverter defibrillator proarrhythmia: Case report and review of the literature. PACE 1991;14:1326-1329.
10. Schöhl W, Trappe HJ, Lichtlen RR: Acceptance and quality of life after implantation of the automatic cardioverter defibrillator. Z Kardiol 1994;83:927-932.
11. Johnson NJ, Marchlinski FE: Arrhythmias induced by antitachycardia therapy due to diagnostic nonspecificity. J Am Coll Cardiol 1991;18:1418-1425.
12. Pinski SL, Fahy GJ: The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995;92:1651-1664.
13. Weber M, Block M, Brunn J, et al: Proarrhythmic effects of inappropriate implantable cardioverter/defibrillator therapies: Incidence, causes and prevention. (Abstract) Eur Heart J 1995;16:221.
14. Rosenqvist M, Beyer T, Block M, et al., for the European Jewel Investigators: Adverse events in patients with implantable cardioverter defibrillators: A prospective study. Circulation 1998;8:663-670.
15. Higgins SL, Lee RS, Kramer RL: Stability: An ICD detection criterion for discriminating atrial fibrillation from ventricular tachycardia. J Cardiovasc Electrophysiol 1995;6:1081-1088.
16. Swerdlow CD, Chen PS, Kass RM, et al: Discrimination of ventricular tachyarrhythmia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1342-1355.
17. Neuzner J, Pitschner HF, Schlepper M: Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. PACE 1995;18:539-547.
18. Block M, Lamp B, Weber M, et al: Follow-up techniques in patients with ICDs. In Vardas PE, ed: Cardiac Arrhythmias, Pacing and Electrophysiology. Kluwer Academic Publishers, Dordrecht, Niederlande, 1998, pp. 317-327.
19. García-Alberola A, Yli-Mäyry S, Block M, et al: RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation 1996;93:295-300.
20. Kelly PA, Mann DE, Reiter MJ, et al: Atrial fibrillation after impiantable defibrillator implantation. PACE 1995;18:379-385.
21. Prystowsky EN, Benson DW, Fuster V, et al: Management of patients with atrial fibrillation. Circulation 1996;93:1262-1277.
22. Brignoie M, Menozzi C: Control of rapid heart rate in patients with atrial fibrillation: Drugs or ablation? PACE 1996;19:348-356.
23. Brachmann J, Seidl K, Hauer B, et al: Intracardiac electrogram width measurement for improved tachycardia discrimination: Initiai results of a new implantable cardioverter-defibrillator. (Abstract) J Am Coll Cardiol 1996;27:96A.
24. Shieh MM, Clem L, Malden L, et al: Improved supraventricular and ventricular tachycardia discrimination using electrogram morphology in an implantable cardioverter defibrillator. G Ital Cardiol 1998;28:245-251.
25. Lavergne T, Daubert J-C, Chauvin M, et al: Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997;20:182-188.
26. Geibel A, Zehender M, Brugada P: Changes in cycle length at the onset of sustained tachycardias: Importance for antitachycardiac pacing. Am Heart J 1988;115:588-592.
27. Swerdlow CD, Ahern T, Chen PS, et al: Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;24:416-424.